BLACK mobile logo

california

health

The CDC Has a New Director – Now Comes the Hard Part

August 19, 2026

The Senate confirmation of CDC Director Erica Schwartz in August 2026 marks only the second time a CDC director has faced this process, which was implemented after COVID-19 to increase oversight of this crucial public health position. Schwartz, a retired rear admiral with experience as deputy surgeon general, assumes leadership during multiple simultaneous health crises including historic measles outbreaks, foodborne illness investigations, and a major Ebola outbreak in Central Africa. Her confirmation hearing created a public record of her commitments on vaccines and scientific integrity, though concerns remain about whether she will resist political pressure from the administration, which has already reduced CDC staffing by nearly one-third and altered childhood vaccine recommendations.

Who is affected

  • CDC Director Erica Schwartz
  • CDC workforce (reduced by nearly one-third between January 2025 and June 2026)
  • The U.S. Senate, particularly the Committee on Health, Education, Labor and Pensions
  • HHS Secretary Robert F. Kennedy Jr. and the Trump administration
  • Patients affected by measles outbreaks (2,566 confirmed cases and 38 outbreaks as of August 13, 2026)
  • Individuals sickened by cyclospora outbreaks (more than 9,481 confirmed illnesses including two deaths in 17 states)
  • Populations in the Democratic Republic of Congo and Uganda affected by Ebola (over 3,600 confirmed cases)
  • American families and children subject to changed federal childhood immunization schedules
  • State and local health departments, epidemiologists, laboratory experts, and international health partners
  • The general American public relying on CDC guidance and disease prevention

What action is being taken

  • The CDC is tracking multiple measles outbreaks
  • The CDC is investigating a multistate cyclospora outbreak linked to iceberg lettuce and other produce
  • The CDC is supporting the response to the Ebola outbreak in Central Africa
  • The Trump administration is reshaping federal childhood vaccine recommendations
  • The World Health Organization is reporting on the Ebola outbreak cases
  • The CDC is responding to continuing measles outbreaks through case detection, vaccination, and contact tracing

Why it matters

  • The Senate confirmation process for the CDC director is critically important because it creates public accountability for one of the nation's most consequential public health positions during a period of multiple simultaneous disease outbreaks and increasing politicization of public health. The confirmation hearing establishes a public record of the director's commitments regarding scientific integrity, evidence-based decision-making, and resistance to political pressure, which provides a standard for evaluating future actions and strengthens Congressional oversight. However, the significance extends beyond the confirmation itself: the CDC is simultaneously managing historic measles outbreaks, foodborne illness investigations, and international disease threats while operating with drastically reduced staffing and facing political interference in vaccine policy. The director's ability to maintain scientific independence and provide accurate public health guidance—even when it conflicts with administration preferences—will directly impact disease prevention and control efforts that affect millions of Americans and global populations.

What's next

  • Congress could extend protections similar to those in the Foundations for Evidence-Based Policymaking Act to other CDC products, including outbreak reports, case counts, vaccine recommendations, and the Morbidity and Mortality Weekly Report
  • Congress could pass the Scientific Integrity Act (repeatedly introduced but not yet passed) to require federal science agencies including the CDC to adopt and enforce scientific integrity policies
  • Congress could write authority into law giving the CDC the ability to release certain data and recommendations without prior approval from political offices and require documentation and disclosure of any overrides
  • The key question is whether Congress and the administration will provide the agency with adequate capacity, funding, and long-term support to perform its work effectively

Read full article from source: The San Diego Voice & Viewpoint

The CDC Has a New Director – Now Comes the Hard Part